# Zai Lab Limited

> Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

**Wikidata**: [Q106221884](https://www.wikidata.org/wiki/Q106221884)  
**Source**: https://4ort.xyz/entity/zai-lab-limited

## Summary
Zai Lab Limited is an innovative, research-based, commercial stage biopharmaceutical company with operations in both China and the U.S. It focuses on developing and delivering transformative medicines for patients globally, specifically targeting cancer, autoimmune diseases, and infectious diseases. The company operates as a public entity, with its securities offered for sale to the general public.

## Key Facts
*   Zai Lab Limited is classified as a public company and a business.
*   It operates within the pharmaceutical industry.
*   The company's headquarters are located in Shanghai.
*   Zai Lab Limited maintains a presence in both China and the U.S.
*   Its primary focus areas for medicine development include cancer, autoimmune diseases, and infectious diseases.
*   The company's securities are traded on the Nasdaq stock exchange under the ticker symbol ZLAB.
*   Zai Lab Limited's International Securities Identification Number (ISIN) is KYG9887T1168.
*   Its Central Index Key (CIK) is 0001704292.
*   The Bloomberg Company ID for Zai Lab Limited is ZLAB:US.
*   Zai Lab Limited's Legal Entity Identifier (LEI) is 549300P2UYQ9U5LY1T58.
*   The company's country of origin or primary operation is the People's Republic of China, as referenced on 2024-09-17.
*   Its legal form is identified by the value Q130192124, as referenced on 2024-09-17.

## FAQs
**What kind of company is Zai Lab Limited?**
Zai Lab Limited is an innovative, research-based, commercial stage biopharmaceutical company. It operates as a public company, meaning its securities are available for purchase by the general public.

**Where is Zai Lab Limited based?**
Zai Lab Limited has a dual presence, with operations in both China and the U.S. Its headquarters are specifically located in Shanghai.

**What medical conditions does Zai Lab Limited focus on?**
The company concentrates its research and development efforts on bringing transformative medicines to patients suffering from cancer, autoimmune diseases, and infectious diseases.

**Is Zai Lab Limited a publicly traded entity?**
Yes, Zai Lab Limited is a publicly traded company. Its shares are listed and can be bought and sold on the Nasdaq stock exchange under the ticker symbol ZLAB.

**What is the industry of Zai Lab Limited?**
Zai Lab Limited operates within the pharmaceutical industry, focusing on the development and commercialization of new medicines.

## Why It Matters
Zai Lab Limited plays a crucial role in global health by focusing on the development of transformative medicines for critical disease areas such as cancer, autoimmune conditions, and infectious diseases. Its research-based approach contributes to medical innovation, aiming to address significant unmet patient needs in China and worldwide. As a public company, it facilitates capital formation within the biopharmaceutical sector, enabling investment in drug discovery and development, which is vital for advancing healthcare solutions and driving economic growth in the industry.

## Notable For
*   Being an innovative, research-based, and commercial stage biopharmaceutical company.
*   Its dedicated focus on developing transformative medicines for cancer, autoimmune, and infectious diseases.
*   Maintaining a significant operational presence across both China and the U.S.
*   Its status as a public company, with its shares actively traded on the Nasdaq stock exchange.

## Body

### Overview
Zai Lab Limited is an innovative, research-based, commercial stage biopharmaceutical company. It maintains a dual presence, with operations based in both China and the U.S. The company's core mission is centered on bringing transformative medicines to patients globally, specifically targeting critical therapeutic areas such as cancer, autoimmune diseases, and infectious diseases.

### Corporate Identity and Structure
Zai Lab Limited is formally classified as a public company and operates as a business entity within the pharmaceutical industry. Its headquarters are situated in Shanghai, and its primary country of operation or incorporation is the People's Republic of China, as documented on September 17, 2024. The company's legal form is identified by the value Q130192124, with its reference also dated September 17, 2024. This structure allows Zai Lab Limited to offer its securities for sale to the general public, distinguishing it from private enterprises.

### Business Focus and Therapeutic Areas
As an innovative and research-based entity, Zai Lab Limited is dedicated to the discovery, development, and commercialization of new pharmaceutical products. The company is in a commercial stage, indicating that it has products on the market or nearing market entry. Its strategic focus is on bringing transformative medicines to patients, with a particular emphasis on three major disease categories:
*   **Cancer:** Addressing various forms of oncological conditions.
*   **Autoimmune Diseases:** Developing treatments for disorders where the body's immune system attacks its own tissues.
*   **Infectious Diseases:** Creating therapies to combat diseases caused by pathogenic microorganisms.
The company's efforts are aimed at serving patients not only within China but also across the globe.

### Public Company Status and Financial Identifiers
Zai Lab Limited operates as a public company, a form of organization that offers its securities, such as stock, for sale to the general public, typically through a stock exchange. This allows the company to raise capital from a broad base of investors. Its shares are publicly traded on the Nasdaq stock exchange under the ticker symbol ZLAB. As a public company, its ownership is distributed among general public shareholders, and it functions as a type of joint-stock company.

Key financial and corporate identifiers for Zai Lab Limited include:
*   **ISIN (International Securities Identification Number):** KYG9887T1168
*   **Central Index Key (CIK):** 0001704292
*   **Bloomberg Company ID:** ZLAB:US
*   **Legal Entity Identifier (LEI):** 549300P2UYQ9U5LY1T58
*   **Google Knowledge Graph ID:** /g/11c73z5rnk

### Online Presence and Digital Footprint
Zai Lab Limited maintains a robust digital presence to communicate with stakeholders and the public. Its official website is accessible at http://zailaboratory.com/. The company also engages through social media platforms, with a Twitter handle identified as ZaiLab_Global and a LinkedIn profile under the ID "zai-lab." Further corporate information can be found via its Crunchbase organization ID, which is "zai-lab."

## References

1. Global LEI Index